Levetiracetam + Placebo

Phase 3Terminated

1 views this week 0 watching💤 Quiet

Interest: 32/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Epilepsy, Post-Traumatic

Conditions

Epilepsy, Post-Traumatic

Trial Timeline

Nov 1, 2007 → May 1, 2010

NCT ID

NCT00566046

About Levetiracetam + Placebo

Levetiracetam + Placebo is a phase 3 stage product being developed by UCB for Epilepsy, Post-Traumatic. The current trial status is terminated. This product is registered under clinical trial identifier NCT00566046. Target conditions include Epilepsy, Post-Traumatic.

What happened to similar drugs?

20 of 20 similar drugs in Epilepsy, Post-Traumatic were approved

Approved (20) Terminated (6) Active (0)

✅ZonegranEisaiApproved

✅Perampanel + PlaceboEisaiApproved

✅perampanelEisaiApproved

✅Perampanel Oral TabletEisaiApproved

✅PerampanelEisaiApproved

✅zonisamide low dose group + zonisamide high dose groupEisaiApproved

✅Zonisamide at targeted daily doses of 100-500 mg/day + Placebo administered to match targeted daily doses of 100-500 mg/dayEisaiApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00291213	Phase 3	Completed	—	—	Tardive Dyskinesia
NCT01228747	Phase 3	Completed	Oct 1, 2010	May 1, 2014	Epilepsy
NCT00566046	Phase 3	Terminated	Nov 1, 2007	May 1, 2010	Epilepsy, Post-Traumatic
NCT00291733	Phase 2	UNKNOWN	May 1, 2006	Oct 1, 2007	Levodopa Induced Dyskinesia
NCT00254657	Pre-clinical	Completed	Mar 1, 2004	Apr 1, 2005	Fibromyalgia
NCT00615615	Phase 3	Completed	Sep 1, 1999	Mar 1, 2003	Epilepsy

Competing Products

20 competing products in Epilepsy, Post-Traumatic

See all competitors

Product	Company	Stage	Hype Score
perampanel	Eisai	Phase 2	35
Lacosamide	UCB	Phase 3	40
Zonisamide + Placebo	Eisai	Phase 3	32
Zonegran	Eisai	Approved	35
perampanel + perampanel	Eisai	Phase 1	29
Perampanel + Placebo	Eisai	Approved	35
perampanel	Eisai	Approved	35
E2007 + Placebo	Eisai	Phase 2	35
Placebo + Rufinamide	Eisai	Phase 3	40
E2007 (perampanel) + Placebo	Eisai	Phase 2	35
Perampanel Oral Tablet	Eisai	Approved	43
perampanel	Eisai	Phase 3	40
Perampanel	Eisai	Pre-clinical	26
Zonisamide + Carbamazepine	Eisai	Phase 3	40
Perampanel	Eisai	Approved	43
Perampanel and Microgynon-30 + Perampanel and Microgynon-30	Eisai	Phase 1	29
Perampanel	Eisai	Phase 2	35
Zonisamide + Placebo	Eisai	Phase 3	40
zonisamide low dose group + zonisamide high dose group	Eisai	Approved	43
E2007 + E2007 + Placebo	Eisai	Phase 2	35